SCHEMBL10659971

SCHEMBL10659971

CCCCCCCCNC(=O)OCc1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.68
TGM2 P21980 1/20 0.68
LMNA P02545 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
FAAH O00519 1/20 0.62
KEAP1 Q14145 2/20 0.61
NFE2L2 Q16236 2/20 0.61
SIRT2 Q8IXJ6 8/20 0.60
SIRT1 Q96EB6 5/20 0.60
SIRT3 Q9NTG7 4/20 0.58
MAPT P10636 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MEN1 O00255 1/20 0.57
ALDH1A1 P00352 1/20 0.57
HPGD P15428 1/20 0.57
KMT2A Q03164 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3364812 1.00 HTT (0.68) HTTTGM2LMNASMN1; SMN2FAAH
SCHEMBL11973884 1.00 HTT (0.68) HTTTGM2LMNASMN1; SMN2FAAH
SCHEMBL28969063 1.00 HTT (0.68) HTTTGM2LMNASMN1; SMN2FAAH
SCHEMBL10599151 1.00 HTT (0.68) HTTTGM2LMNASMN1; SMN2FAAH
SCHEMBL16692630 1.00 HTT (0.68) HTTTGM2LMNASMN1; SMN2FAAH
Hydrochloric Acid SCHEMBL29541034 0.98 HTT (0.67) HTTTGM2LMNASMN1; SMN2FAAH
Bromide SCHEMBL29171369 0.98 HTT (0.67) HTTTGM2LMNASMN1; SMN2FAAH
Hydrochloric Acid SCHEMBL30025835 0.98 HTT (0.67) HTTTGM2LMNASMN1; SMN2FAAH
SCHEMBL8290406 0.98 HTT (0.70) HTTTGM2LMNASMN1; SMN2FAAH
SCHEMBL9325641 0.96 TGM2 (0.64) HTTTGM2LMNASMN1; SMN2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023144798-A1 IONIZABLE CATIONIC LIPIDS FOR LIPID NANOPARTICLES GENEVANT SCIENCES GMBH (CH) 2023-08-03 WO disclosed
CN-116322700-A Novel PLK1 degradation inducing compounds 厄普特拉株式会社 2023-06-23 CN disclosed
CN-116261458-A Novel PLK1 degradation inducing compounds 厄普特拉株式会社 2023-06-13 CN disclosed
CN-115279373-A Cyanopyrimidine inhibitors of EGFR/HER2 达纳-法伯癌症研究所股份有限公司 2022-11-01 CN disclosed
EP-3293175-B1 METHODS FOR PURIFICATION OF SERINE PROTEASES ALEXION PHARMA INC (US) 2021-12-01 EP disclosed
CN-111499580-A Substituted diaminocarboxamides and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith 西格诺药品有限公司 2020-08-07 CN disclosed
CN-111471021-A Substituted diaminocarboxamides and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith 西格诺药品有限公司 2020-07-31 CN disclosed
CN-105001165-B Substituted diaminopyrimidines, compositions thereof, and methods of treatment therewith 西格诺药品有限公司 2020-06-23 CN disclosed
CN-106946795-B Substituted diaminocarboxamides and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith 西格诺药品有限公司 2020-06-02 CN disclosed
EP-3293175-A1 METHODS FOR PURIFICATION OF SERINE PROTEASES Portola Pharmaceuticals, Inc. (US) 2018-03-14 EP disclosed
EP-2938596-B1 METHODS FOR PURIFICATION OF SERINE PROTEASES PORTOLA PHARM INC (US) 2017-11-01 EP disclosed
CN-1224001-A Process for preparation of carbonates and polycarbonates MONSANTO CO (US) 1999-07-28 CN disclosed
US-4725680-A AMINATION, CLEAVAGE, NEUTRALIZATION SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1988-02-16 US disclosed